REPLIGEN CORP Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
REPLIGEN CORP (RGEN) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 651.26 thousand shares for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2018-11-01
- REPLIGEN CORP incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2018-09-30 was 651.26K shares, a 34.49% increase year-over-year.
- REPLIGEN CORP incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2018-06-30 was 480.56K shares, a 9.86% increase year-over-year.
- REPLIGEN CORP incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2017-09-30 was 484.24K shares, a 9.27% decline year-over-year.
- REPLIGEN CORP incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2017-06-30 was 437.43K shares, a 16.81% decline year-over-year.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month |
|---|---|---|---|
| 2018-09-30 | 651.26K shares 10-Q · filed 2018-11-01 | 511.43K shares 10-Q · filed 2018-11-01 | |
| 2018-06-30 | 480.56K shares 10-Q · filed 2018-08-02 | 433.96K shares 10-Q · filed 2018-08-02 | |
| 2017-09-30 | 484.24K shares 10-Q · filed 2018-11-01 | 454.34K shares 10-Q · filed 2018-11-01 | |
| 2017-06-30 | 437.43K shares 10-Q · filed 2018-08-02 | 433.48K shares 10-Q · filed 2018-08-02 | |
| 2017-03-31 | 490.62K shares 10-Q · filed 2017-05-04 | ||
| 2016-09-30 | 533.75K shares 10-Q · filed 2017-11-09 | 526.09K shares 10-Q · filed 2017-11-09 | |
| 2016-06-30 | 525.83K shares 10-Q · filed 2017-08-03 | 525.32K shares 10-Q · filed 2017-08-03 | |
| 2016-03-31 | 468.89K shares 10-Q · filed 2017-05-04 | ||
| 2015-09-30 | 764.56K shares 10-Q · filed 2016-11-03 | 757.62K shares 10-Q · filed 2016-11-03 | |
| 2015-06-30 | 800.22K shares 10-Q · filed 2016-08-04 | 754.15K shares 10-Q · filed 2016-08-04 | |
| 2015-03-31 | 695.75K shares 10-Q · filed 2016-05-05 | ||
| 2014-09-30 | 650.37K shares 10-Q · filed 2015-11-05 | 807.01K shares 10-Q · filed 2015-11-05 | |
| 2014-06-30 | 842.69K shares 10-Q · filed 2015-08-06 | 865.28K shares 10-Q · filed 2015-08-06 | |
| 2014-03-31 | 868.18K shares 10-Q · filed 2015-05-08 | ||
| 2013-09-30 | 693.48K shares 10-Q · filed 2014-11-07 | 699.64K shares 10-Q · filed 2014-11-07 | |
| 2013-06-30 | 673.46K shares 10-Q · filed 2014-08-11 | 672.25K shares 10-Q · filed 2014-08-11 | |
| 2013-03-31 | 614.82K shares 10-Q · filed 2014-05-09 | ||
| 2012-09-30 | 308.21K shares 10-Q · filed 2013-11-08 | 290.40K shares 10-Q · filed 2013-11-08 | |
| 2012-06-30 | 303.95K shares 10-Q · filed 2013-08-07 | 285.05K shares 10-Q · filed 2013-08-07 | |
| 2012-03-31 | 280.17K shares 10-Q · filed 2013-05-07 | ||
| 2011-09-30 | 137.03K shares 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |